Home/Pipeline/Refractive Surgery Platform

Refractive Surgery Platform

Myopia Correction

DevelopmentPreclinical

Key Facts

Indication
Myopia Correction
Phase
Development
Status
Preclinical
Company

About VivaVision Biotech

Chinese ophthalmic medical device company developing AI-enhanced diagnostic and therapeutic technologies for retinal diseases and refractive surgery.

View full company profile

Therapeutic Areas